陳 志榮

Medicine & Life Sciences

1. Nasopharyngeal Carcinoma 100%
2. Human Herpesvirus 4 58%
3. Neoplasms 51%
4. Neoplasm Metastasis 41%
5. Carcinoma 26%
6. Epstein-Barr virus EBV-associated membrane antigen 25%
7. Marginal Zone B-Cell Lymphoma 20%
8. Hepatocellular Carcinoma 19%
9. Squamous Cell Carcinoma of Head and Neck 19%
10. Membrane Proteins 19%
11. Glioblastoma 19%
12. Survival 18%
13. Colorectal Neoplasms 18%
14. Drug Therapy 18%
15. Breast Neoplasms 18%
16. Lymphoma 18%
17. Down-Regulation 18%
18. Squamous Cell Carcinoma 15%
19. Helicobacter pylori 15%
20. Biopsy 15%
21. Salivary Glands 15%
22. Genes 15%
23. Stomach 14%
24. Lung 14%
25. Growth 14%
26. Staining and Labeling 14%
27. Breast 14%
28. Up-Regulation 13%
29. Catenins 13%
30. Recurrence 13%
31. Colonic Neoplasms 12%
32. Epithelial-Mesenchymal Transition 12%
33. Prostatic Neoplasms 12%
34. Proteins 12%
35. Triple Negative Breast Neoplasms 12%
36. Therapeutics 11%
37. RON protein 11%
38. Cell Line 11%
39. Stomach Neoplasms 11%
40. Gastric Mucosa 10%
41. Multiple Drug Resistance 10%
42. Epithelial Cells 10%
43. Fluorouracil 10%
44. Biomarkers 10%
45. Drug Resistance 9%
46. Pylorus 9%
47. Peripheral T-Cell Lymphoma 9%
48. Apoptosis 9%
49. Carcinogenesis 9%
50. Nasopharyngeal Neoplasms 9%